Atlas Trials

A Study of the Pharmacokinetics, Safety and Tolerability of Single Doses of VR647 Inhalation Suspension Administered Using the VR647 Inhalation System in Children With Wheezing, Reactive Airway Disease or Mild Asthma

Clinical trial NCT03421730 · COMPLETED

Trial details

NCT number
NCT03421730
Sponsor
Vectura Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
WheezingReactive Airway DiseaseMild Asthma
Start date
2017-12-18
Primary completion
2018-03-21
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.